S

Sun Pharma Advanced Research Co Ltd
NSE:SPARC

Watchlist Manager
Sun Pharma Advanced Research Co Ltd
NSE:SPARC
Watchlist
Price: 169.82 INR 5.28% Market Closed
Market Cap: 55.1B INR

Intrinsic Value

The intrinsic value of one SPARC stock under the Base Case scenario is 3 683.43 INR. Compared to the current market price of 169.82 INR, Sun Pharma Advanced Research Co Ltd is Undervalued by 95%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SPARC Intrinsic Value
3 683.43 INR
Undervaluation 95%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Fundamental Analysis

Izmir Demir Celik Sanayi AS
IST:IZMDC.E
TR
Metals & Mining
Market Cap
7.5B TRY
IPO
Jan 24, 1986
TR
Metals & Mining
Market Cap
7.5B TRY
IPO
Jan 24, 1986
Price
₺false
EPS
₺false
Sun Pharma Advanced Research Co Ltd
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Sun Pharma Advanced Research Co Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Sun Pharma Advanced Research Co Ltd

Current Assets 905.5m
Cash & Short-Term Investments 98m
Receivables 136.1m
Other Current Assets 671.4m
Non-Current Assets 2.3B
Long-Term Investments 256.1m
PP&E 1B
Intangibles 426.4m
Other Non-Current Assets 573.6m
Efficiency

Free Cash Flow Analysis
Sun Pharma Advanced Research Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Sun Pharma Advanced Research Co Ltd

Revenue
611.4m INR
Cost of Revenue
-248.8m INR
Gross Profit
362.5m INR
Operating Expenses
-4.2B INR
Operating Income
-3.9B INR
Other Expenses
-2.4m INR
Net Income
-3.9B INR
Fundamental Scores

SPARC Profitability Score
Profitability Due Diligence

Sun Pharma Advanced Research Co Ltd's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Gross Profit
Exceptional Revenue Growth Forecast
Negative 1-Year Revenue Growth
31/100
Profitability
Score

Sun Pharma Advanced Research Co Ltd's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

SPARC Solvency Score
Solvency Due Diligence

Sun Pharma Advanced Research Co Ltd's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
43/100
Solvency
Score

Sun Pharma Advanced Research Co Ltd's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SPARC Price Targets Summary
Sun Pharma Advanced Research Co Ltd

There are no price targets for SPARC.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Sun Pharma Advanced Research Co Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for SPARC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

SPARC Insider Trading
Buy and sell transactions by insiders